This major event will bring together the world's leading experts in thoracic oncology and precision medicine, with the aim of sharing the latest advances in the understanding, diagnosis and treatment of lung cancer.
The programme draws on the expertise of leading figures in research and clinical practice, such as John V. Heymach and Ignacio Wistuba, as well as French specialists such as Catherine Alix-Panabières and Paul Hofman. Discussions will focus on the integration of artificial intelligence in diagnosis, innovations in biomarkers and liquid biopsy, and issues related to treatment resistance. The translational approach and new molecular modelling tools will complement these perspectives. Lung cancer remains the leading cause of cancer death worldwide, with more than 1.8 million deaths each year. This international congress provides a platform for discussion to strengthen precision medicine and accelerate therapeutic innovation.
Opening times
Opening times
Each friday from 3 October 2025 until 4 October 2025
